Research

Hormonal

Retatrutide, a triple-hormone receptor agonist (GLP-1/GIP/Glucagon), can cause intractable, secretory diarrhea and acute kidney injury, particularly when used off-label via unregulated online sources with unestablished dosing protocols.

If you are using retatrutide or similar GLP-1 agonists obtained from online sources, be aware that dosing is not standardized and risks are higher. Intractable diarrhea and kidney injury are serious potential side effects. Seek regulated medical care for weight loss management to ensure safe dosing and monitoring.

LimitedSupportsLOW confidence
A clinical impression of intractable diarrhea induced by retatrutide was formed. The mechanism of diarrhea was thought to be secretory... The patient reported onset of diarrhea over the last 7 days... He started on a self-determined dose of 10 mg subcutaneously weekly... increased the dose to 20 mg... inadvertently repeated the dose the following day.
Opeyemi Komolafe · Annals of Internal Medicine Clinical Cases · 2026

Why this rating

Single case report (n=1), though the clinical presentation and exclusion of other causes are detailed.

Source

Retatrutide-Induced Intractable Diarrhea

Opeyemi Komolafe · Annals of Internal Medicine Clinical Cases · 2026

DOI 10.7326/aimcc.2025.1218

case_report · n=1Cited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →